PETA Science Consortium International e.V., the Physicians Committee for Responsible Medicine (PCRM), and the Alternatives Research and Development Foundation (ARDF) are offering grants for free catalogue recombinant antibodies for use in research and testing.

A team of researchers from the Natural and Medical Sciences Institute in Reutlingen (NMI), together with colleagues from the Medical Faculty of the Tübingen University as well as from the Fraunhofer Institute IGB, has developed an obesity model on a chip. The model is called Mix & Match and integrates all important cellular components that can also be found in human white adipose tissue.

A cell-based neuropathy disease model on-chip developed by Hesperos Inc. in Florida and colleagues is able to successfully recapitulate the neurophysiological features of two rare autoimmune demyelinating neuropathies. Additionally, it has been shown that the model is suitable for assessing the efficacy of new therapeutics.

Scientists at the Technical University of Berlin and colleagues have successfully developed an in vitro approach of a human neuroblastoma in a surrounding human cellular environment and treated it with drugs. They succeeded in treating the metastasis. At the same time, they were able to observe the influence on the surrounding tissue.